Aspen Aerogels, Inc. (NYSE:ASPN) Receives $12.67 Average Target Price from Analysts

Aspen Aerogels, Inc. (NYSE:ASPN) has earned an average rating of “Hold” from the ten analysts that are presently covering the company, Marketbeat reports. Three analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation, four have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $12.6667.

Several analysts have recently weighed in on ASPN shares. Barclays reduced their price objective on shares of Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating for the company in a research report on Friday, November 7th. Zacks Research cut shares of Aspen Aerogels from a “hold” rating to a “strong sell” rating in a research report on Monday, November 10th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a report on Monday. Finally, Canaccord Genuity Group cut their target price on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating on the stock in a research report on Friday, November 7th.

Insider Buying and Selling

In other Aspen Aerogels news, CEO Donald R. Young sold 56,845 shares of the business’s stock in a transaction that occurred on Thursday, November 13th. The stock was sold at an average price of $3.23, for a total value of $183,609.35. Following the completion of the sale, the chief executive officer owned 494,011 shares in the company, valued at approximately $1,595,655.53. The trade was a 10.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 4.30% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Aspen Aerogels

Institutional investors have recently modified their holdings of the business. Nisa Investment Advisors LLC boosted its stake in shares of Aspen Aerogels by 1,094.8% during the second quarter. Nisa Investment Advisors LLC now owns 4,791 shares of the construction company’s stock worth $28,000 after buying an additional 4,390 shares during the period. SBI Securities Co. Ltd. raised its stake in Aspen Aerogels by 67.3% during the 2nd quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company’s stock valued at $38,000 after acquiring an additional 2,551 shares during the last quarter. Acadian Asset Management LLC purchased a new stake in Aspen Aerogels during the 1st quarter valued at approximately $43,000. Tower Research Capital LLC TRC lifted its position in Aspen Aerogels by 184.6% during the 2nd quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company’s stock worth $43,000 after acquiring an additional 4,693 shares during the period. Finally, Olympiad Research LP purchased a new position in shares of Aspen Aerogels in the 3rd quarter valued at approximately $70,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Aspen Aerogels Stock Down 4.7%

Shares of NYSE ASPN opened at $2.94 on Thursday. The business has a 50-day moving average of $5.19 and a two-hundred day moving average of $6.28. The company has a market capitalization of $242.58 million, a price-to-earnings ratio of -0.79 and a beta of 2.95. Aspen Aerogels has a 1 year low of $2.92 and a 1 year high of $14.30. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.94 and a quick ratio of 3.33.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Thursday, November 6th. The construction company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.05). The business had revenue of $73.02 million for the quarter, compared to analyst estimates of $73.42 million. Aspen Aerogels had a negative return on equity of 0.20% and a negative net margin of 86.52%.Aspen Aerogels’s revenue was down 37.8% on a year-over-year basis. During the same period last year, the business posted ($0.17) EPS. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. On average, analysts forecast that Aspen Aerogels will post 0.17 earnings per share for the current fiscal year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.